Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy

Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy

(2012) T. Molnár et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study

(2012) Casper Steenholdt et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

(2011) Edouard Louis et al.   GASTROENTEROLOGY

Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission

(2011) Kofi Clarke et al.   INFLAMMATORY BOWEL DISEASES

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?

(2010) Geert R D'Haens et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical implications of mucosal healing for the management of IBD

(2009) Guillaume Pineton de Chambrun et al.   Nature Reviews Gastroenterology & Hepatology